Neffy
DrugEpinephrine nasal spray
NCT Number: NCT06834165
The study is to assess the safety of neffy or IM Adrenalin in patients who are experiencing allergic reactions after an OFC, allergen Immunotherapy (AIT), or other allergy challenge that may require epinephrine intervention.
Interested in participating?
Request Info4 year and older
All sexes
Interventional
Phase 4
Orso Health, Inc., La Jolla, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Epinephrine nasal spray
Epinephrine injection
Time frame: 2 hours
Contact information is provided by the study sponsor or research team.
ARS Pharmaceuticals, Inc.
Industry
A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07195929
Allergic Reactions, Allergic Skin Reaction
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
View Trial DetailsNCT00894634
Allergic Reactions, Hypersensitivity
View Trial DetailsNCT00837837
Allergic Reactions, Hypersensitivity
View Trial DetailsNCT01204866
Allergic Reactions, Hypersensitivity
Overland Park, Kansas, United States
View Trial Details